Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Enhanced Antimicrobial Potency and Therapeutic Index of a Defined C12 Quaternary Ammonium Compound

Created on 31 Oct 2026

Authors

Kist, M. M., Wulandari, I. G. A. I., Buell, J. F., Morici, L. A., ROY, C. J.

Abstract

Skin and soft tissue infections (SSTIs) remain a major clinical burden and are complicated by antimicrobial resistance, polymicrobial infections, and biofilm-mediated therapeutic tolerance. Topical antimicrobials can provide localized activity while reducing systemic exposure, but currently available agents are limited by narrow spectra, cytotoxicity, poor antibiofilm activity, and resistance development. We evaluated C12-alkyl(ethylbenzyl)dimethyl ammonium chloride (EQ12), a next-generation quaternary ammonium compound, in vitro as a topical antimicrobial candidate for leading bacterial causes of SSTIs. Broth microdilution assays were used to determine minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) against methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant S. aureus (MRSA), Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Species-selective plating was used to assess bactericidal activity in staphylococcal-P. aeruginosa co-cultures. Crystal violet assays quantified biofilm inhibition against MRSA, P. aeruginosa, and A. baumannii, and serial passage experiments assessed resistance emergence over 14 passages. EQ12 inhibited all species tested, with MICs of 2.3 to 40 micrograms/mL and MBCs of 4.7 to 40 micrograms/mL. EQ12 outperformed benzalkonium chloride and povidone-iodine against Gram-negative isolates and retained bactericidal activity in mixed cultures, although staphylococcal susceptibility decreased in the presence of P. aeruginosa. EQ12 inhibited biofilm formation at sub-MIC to near-MIC concentrations and did not induce resistance in MRSA, P. aeruginosa, or A. baumannii, unlike comparator topical antibiotics. These findings support further development of EQ12 as a topical antimicrobial for SSTI-associated pathogens.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 31 Oct 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement